EYPT - EyePoint Pharmaceuticals prices upsized $200 million stock offering
2023-12-06 01:37:20 ET
More on EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert Looks Real Deal
- Shorting EyePoint Pharmaceuticals Ahead Of Davio-2 Wet-AMD Data: Potential 78% Gain
- Countdown To Clarity: EyePoint's December Data Delivery
- EyePoint commences $175M stock offering to advance wet AMD therapy into late-stage
For further details see:
EyePoint Pharmaceuticals prices upsized $200 million stock offering